Trial Information

Summary: Clinical Studies of Patients with Paraneoplastic Neurologic Disorders

We are studying patients with paraneoplastic neurologic disorders (The Hu syndrome, a.k.a. Paraneoplastic Subacute Sensory Neuropathy/Encephalomyelitis or Limbic Encephalopathy, and The Ri Syndrome, a.k.a. Paraneoplastic Opsoclonus-Myoclonus Ataxia) in two IRB-approved protocols at the Rockefeller University Clinical Research Center. One study is aimed at furthering our understanding of the cause of these disorders, and a second is a treatment protocol based on our laboratory studies.

All patients with paraneoplastic neurologic disorders are eligible, including patients with:

• Paraneoplastic Cerebellar Degeneration
• The Hu Syndrome
  • Paraneoplastic Subacute Sensory Neuropathy/Encephalomyelitis
  • Limbic Encephalopathy
• Paraneoplastic Opsoclonus-Myoclonus Ataxia (The Ri Syndrome)

If you would like to learn more about participating in this study, please send an e-mail message using the form below.